Name | Label | Folder | |
---|---|---|---|
ostrd1
Oral steroids (Sleep Heart Health Study Visit One (SHHS1))
|
Oral steroids (Sleep Heart Health Study Visit One (SHHS1))
Participant taking ORAL STEROIDS within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review. |
Medical History/Medications/SHHS1 | |
tca1
Tricylic Anti-Depressants (Sleep Heart Health Study Visit One (SHHS1))
|
Tricylic Anti-Depressants (Sleep Heart Health Study Visit One (SHHS1))
Participant taking TRICYLIC ANTI-DEPRESSANTS within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review. |
Medical History/Medications/SHHS1 | |
ace2
angiotensin-converting-enzyme inhibitor (ACE) inhibitors without diuretics (Sleep Heart Health Study Visit Two (SHHS2))
|
angiotensin-converting-enzyme inhibitor (ACE) inhibitors without diuretics (Sleep Heart Health Study Visit Two (SHHS2))
Participant taking angiotensin-converting-enzyme inhibitor (ACE) INHIBITORS WITHOUT DIURETICS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review. |
Medical History/Medications/SHHS2 | |
aced2
angiotensin-converting-enzyme inhibitor (ACE) inhibitors with diuretics (Sleep Heart Health Study Visit Two (SHHS2))
|
angiotensin-converting-enzyme inhibitor (ACE) inhibitors with diuretics (Sleep Heart Health Study Visit Two (SHHS2))
Participant taking angiotensin-converting-enzyme inhibitor (ACE) INHIBITORS WITH DIURETICS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review. |
Medical History/Medications/SHHS2 | |
benzod2
Benzodiazepines (Sleep Heart Health Study Visit Two (SHHS2))
|
Benzodiazepines (Sleep Heart Health Study Visit Two (SHHS2))
Participant taking BENZODIAZEPINES within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review. |
Medical History/Medications/SHHS2 | |
beta2
Beta-Blockers Without Diuretics (Sleep Heart Health Study Visit Two (SHHS2))
|
Beta-Blockers Without Diuretics (Sleep Heart Health Study Visit Two (SHHS2))
Participant taking BETA-BLOCKERS WITHOUT DIURETICS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review. |
Medical History/Medications/SHHS2 | |
betad2
Beta-Blockers With Diuretics (Sleep Heart Health Study Visit Two (SHHS2))
|
Beta-Blockers With Diuretics (Sleep Heart Health Study Visit Two (SHHS2))
Participant taking BETA-BLOCKERS WITH DIURETICS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review. |
Medical History/Medications/SHHS2 | |
diur2
Any Diuretic (Sleep Heart Health Study Visit Two (SHHS2))
|
Any Diuretic (Sleep Heart Health Study Visit Two (SHHS2))
Participant taking ANY DIURETIC within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review. |
Medical History/Medications/SHHS2 | |
htnmed2
Any Anti-Hypertensive Medication (Sleep Heart Health Study Visit Two (SHHS2))
|
Any Anti-Hypertensive Medication (Sleep Heart Health Study Visit Two (SHHS2))
Participant taking ANY ANTI-HYPERTENSIVE MEDICATION within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review. |
Medical History/Medications/SHHS2 | |
insuln2
Insulins (Sleep Heart Health Study Visit Two (SHHS2))
|
Insulins (Sleep Heart Health Study Visit Two (SHHS2))
Participant taking INSULINS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review. |
Medical History/Medications/SHHS2 | |
istrd2
Inhaled Steroids For Asthma (Sleep Heart Health Study Visit Two (SHHS2))
|
Inhaled Steroids For Asthma (Sleep Heart Health Study Visit Two (SHHS2))
Participant taking INHALED STEROIDS FOR ASTHMA within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review. |
Medical History/Medications/SHHS2 | |
lipid2
Any Lipid-Lowering Medication (Sleep Heart Health Study Visit Two (SHHS2))
|
Any Lipid-Lowering Medication (Sleep Heart Health Study Visit Two (SHHS2))
Participant taking ANY LIPID-LOWERING MEDICATION within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review. |
Medical History/Medications/SHHS2 | |
mlpd2
Miscellaneous Lipid-Lowering Drugs (Sleep Heart Health Study Visit Two (SHHS2))
|
Miscellaneous Lipid-Lowering Drugs (Sleep Heart Health Study Visit Two (SHHS2))
Participant taking MISCELLANEOUS LIPID-LOWERING DRUGS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review. |
Medical History/Medications/SHHS2 | |
oaia2
Oral Anti-Inflammatory Asthma Drugs (Leukotriene Receptor Antagonists And Inhibitors Of Lipo-Oxygenase) (Sleep Heart Health Study Visit Two (SHHS2))
|
Oral Anti-Inflammatory Asthma Drugs (Leukotriene Receptor Antagonists And Inhibitors Of Lipo-Oxygenase) (Sleep Heart Health Study Visit Two (SHHS2))
Participant taking ORAL ANTI-INFLAMMATORY ASTHMA DRUGS (LEUKOTRIENE RECEPTOR ANTAGONISTS AND INHIBITORS OF LIPO-OXYGENASE) within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review. |
Medical History/Medications/SHHS2 | |
ohga2
Oral Hypoglycemic Agents (Sleep Heart Health Study Visit Two (SHHS2))
|
Oral Hypoglycemic Agents (Sleep Heart Health Study Visit Two (SHHS2))
Participant taking ORAL HYPOGLYCEMIC AGENTS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review. |
Medical History/Medications/SHHS2 | |
ostrd2
Oral Steroids (Sleep Heart Health Study Visit Two (SHHS2))
|
Oral Steroids (Sleep Heart Health Study Visit Two (SHHS2))
Participant taking ORAL STEROIDS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review. |
Medical History/Medications/SHHS2 | |
tca2
Tricylic Anti-Depressants (Sleep Heart Health Study Visit Two (SHHS2))
|
Tricylic Anti-Depressants (Sleep Heart Health Study Visit Two (SHHS2))
Participant taking TRICYLIC ANTI-DEPRESSANTS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review. |
Medical History/Medications/SHHS2 | |
alcoh
Alcohol use (Sleep Heart Health Study Visit One (SHHS1))
|
Alcohol use (Sleep Heart Health Study Visit One (SHHS1))
Usual Alcohol Intake per day |
Medical History/SHHS1 | |
cgpkyr
Cigarette pack-years (Sleep Heart Health Study Visit One (SHHS1))
|
Cigarette pack-years (Sleep Heart Health Study Visit One (SHHS1))
Lifetime cigarette smoking: pack years |
Medical History/SHHS1 | |
parrptdiab
History of Diabetes (Sleep Heart Health Study Visit One (SHHS1))
|
History of Diabetes (Sleep Heart Health Study Visit One (SHHS1))
Parent Cohort reported Diabetes Status |
Medical History/SHHS1 | |
srhype
Self-reported hypertension (HTN) (Sleep Heart Health Study Visit One (SHHS1))
|
Self-reported hypertension (HTN) (Sleep Heart Health Study Visit One (SHHS1)) | Medical History/SHHS1 | |
hi201a
History of Emphysema (Sleep Heart Health Study Visit Two (SHHS2))
|
History of Emphysema (Sleep Heart Health Study Visit Two (SHHS2))
1. Has a doctor ever told you that you have the following? a. Emphysema |
Medical History/SHHS2 | |
hi201b
History of Chronic Bronchitis (Sleep Heart Health Study Visit Two (SHHS2))
|
History of Chronic Bronchitis (Sleep Heart Health Study Visit Two (SHHS2))
1. Has a doctor ever told you that you have the following? b. Chronic bronchitis |
Medical History/SHHS2 | |
hi201c
History of chronic obstructive pulmonary disease (COPD) (Sleep Heart Health Study Visit Two (SHHS2))
|
History of chronic obstructive pulmonary disease (COPD) (Sleep Heart Health Study Visit Two (SHHS2))
1. Has a doctor ever told you that you have the following? c. chronic obstructive pulmonary disease (COPD) |
Medical History/SHHS2 | |
hi201d
History of Asthma (Sleep Heart Health Study Visit Two (SHHS2))
|
History of Asthma (Sleep Heart Health Study Visit Two (SHHS2))
1. Has a doctor ever told you that you have the following? d. Asthma |
Medical History/SHHS2 | |
hi201e
Current Asthma (Sleep Heart Health Study Visit Two (SHHS2))
|
Current Asthma (Sleep Heart Health Study Visit Two (SHHS2))
e. Do you still have asthma? |
Medical History/SHHS2 | |
hi216
History of restless leg syndrome (RLS) (Sleep Heart Health Study Visit Two (SHHS2))
|
History of restless leg syndrome (RLS) (Sleep Heart Health Study Visit Two (SHHS2))
16. Has a doctor ever told you that you have the following? restless leg syndrome (RLS)? |
Medical History/SHHS2 | |
htnderv_s1
Hypertension (HTN) (Sleep Heart Health Study Visit One (SHHS1))
|
Hypertension (HTN) (Sleep Heart Health Study Visit One (SHHS1))
Hypertension (HTN) Status based on 2nd and 3rd blood pressure readings OR being treated with hypertension (HTN) meds |
Medical History/SHHS2 | |
htnderv_s2
Hypertension (HTN) (Sleep Heart Health Study Visit Two (SHHS2))
|
Hypertension (HTN) (Sleep Heart Health Study Visit Two (SHHS2))
Derived hypertension (HTN) classification (based on blood pressure measurements, history of hypertension (HTN) dx, and medication use) |
Medical History/SHHS2 | |
ahi_a0h3
Apnea-Hypopnea Index: (Apneas with no oxygen desaturation threshold used and with or without arousal+ hypopneas with > 30% flow reduction and >= 3% oxygen desaturation and with or without arousal) / hour of sleep from type II polysomnography
|
Apnea-Hypopnea Index: (Apneas with no oxygen desaturation threshold used and with or without arousal+ hypopneas with > 30% flow reduction and >= 3% oxygen desaturation and with or without arousal) / hour of sleep from type II polysomnography
Calculated - Summary metric of sleep disordered breathing events. |
Sleep Monitoring/Polysomnography/Apnea-Hypopnea Indices | |
ahi_a0h3a
Apnea-Hypopnea Index: (Apneas with no oxygen desaturation threshold used and with or without arousal+ hypopneas with > 30% flow reduction and >= 3% oxygen desaturation or with arousal) / hour of sleep from type II polysomnography
|
Apnea-Hypopnea Index: (Apneas with no oxygen desaturation threshold used and with or without arousal+ hypopneas with > 30% flow reduction and >= 3% oxygen desaturation or with arousal) / hour of sleep from type II polysomnography
Calculated - Summary metric of sleep disordered breathing events. The definition for hypopneas is consistent with the following clinical guidelines: (1) American Academy of Sleep Medicine (AASM) 2007 Manual (2012 update) (recommended). Berry RB et al. 2012 (PubMed ID:23066376), and (2) American Academy of Sleep Medicine (AASM) 2015 (recommended) [Berry RB et al. The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications, Version 2.2. American Academy of Sleep Medicine, Darien, IL, 2015.] |
Sleep Monitoring/Polysomnography/Apnea-Hypopnea Indices | |
ahi_a0h4
Apnea-Hypopnea Index: (Apneas with no oxygen desaturation threshold used and with or without arousal+ hypopneas with > 30% flow reduction and >= 4% oxygen desaturation and with or without arousal) / hour of sleep from type II polysomnography
|
Apnea-Hypopnea Index: (Apneas with no oxygen desaturation threshold used and with or without arousal+ hypopneas with > 30% flow reduction and >= 4% oxygen desaturation and with or without arousal) / hour of sleep from type II polysomnography
Calculated - Summary metric of sleep disordered breathing events. The definition of hypopnea events is consistent with the following clinical guidelines: (1) AASM 2012 update (alternative) Berry RB et al. 2012 (PubMed ID:23066376), and (2) AASM 2015 (acceptable) [Berry RB et al. The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications, Version 2.2. American Academy of Sleep Medicine, Darien, IL, 2015.]. |
Sleep Monitoring/Polysomnography/Apnea-Hypopnea Indices | |
ahi_a0h4a
Apnea-Hypopnea Index: (Apneas with no oxygen desaturation threshold used and with or without arousal+ hypopneas with > 30% flow reduction and >= 4% oxygen desaturation or with arousal) / hour of sleep from type II polysomnography
|
Apnea-Hypopnea Index: (Apneas with no oxygen desaturation threshold used and with or without arousal+ hypopneas with > 30% flow reduction and >= 4% oxygen desaturation or with arousal) / hour of sleep from type II polysomnography
Calculated - Summary metric of sleep disordered breathing events |
Sleep Monitoring/Polysomnography/Apnea-Hypopnea Indices | |
ahi_c0h3
Central Apnea-Hypopnea Index: (Central apneas with no oxygen desaturation threshold used and with or without arousal+ hypopneas with > 30% flow reduction and >= 3% oxygen desaturation and with or without arousal) / hour of sleep from type II polysomnography
|
Central Apnea-Hypopnea Index: (Central apneas with no oxygen desaturation threshold used and with or without arousal+ hypopneas with > 30% flow reduction and >= 3% oxygen desaturation and with or without arousal) / hour of sleep from type II polysomnography
Calculated - Summary metric of sleep disordered breathing events. |
Sleep Monitoring/Polysomnography/Apnea-Hypopnea Indices | |
ahi_c0h3a
Central Apnea-Hypopnea Index: (Central apneas with no oxygen desaturation threshold used and with or without arousal+ hypopneas with > 30% flow reduction and >= 3% oxygen desaturation or with arousal) / hour of sleep from type II polysomnography
|
Central Apnea-Hypopnea Index: (Central apneas with no oxygen desaturation threshold used and with or without arousal+ hypopneas with > 30% flow reduction and >= 3% oxygen desaturation or with arousal) / hour of sleep from type II polysomnography
Calculated - Summary metric of sleep disordered breathing events. The definition for hypopneas is consistent with the following clinical guidelines: (1) American Academy of Sleep Medicine (AASM) 2007 Manual (2012 update) (recommended). Berry RB et al. 2012 (PubMed ID:23066376), and (2) American Academy of Sleep Medicine (AASM) 2015 (recommended) [Berry RB et al. The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications, Version 2.2. American Academy of Sleep Medicine, Darien, IL, 2015.] |
Sleep Monitoring/Polysomnography/Apnea-Hypopnea Indices | |
ahi_c0h4
Central Apnea-Hypopnea Index: (Central apneas with no oxygen desaturation threshold used and with or without arousal+ hypopneas with > 30% flow reduction and >= 4% oxygen desaturation and with or without arousal) / hour of sleep from type II polysomnography
|
Central Apnea-Hypopnea Index: (Central apneas with no oxygen desaturation threshold used and with or without arousal+ hypopneas with > 30% flow reduction and >= 4% oxygen desaturation and with or without arousal) / hour of sleep from type II polysomnography
Calculated - Summary metric of sleep disordered breathing events. The definition of hypopnea events is consistent with the following clinical guidelines: (1) AASM 2012 update (alternative) Berry RB et al. 2012 (PubMed ID:23066376), and (2) AASM 2015 (acceptable) [Berry RB et al. The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications, Version 2.2. American Academy of Sleep Medicine, Darien, IL, 2015.]. |
Sleep Monitoring/Polysomnography/Apnea-Hypopnea Indices | |
ahi_c0h4a
Central Apnea-Hypopnea Index: (Central apneas with no oxygen desaturation threshold used and with or without arousal+ hypopneas with > 30% flow reduction and >= 4% oxygen desaturation or with arousal) / hour of sleep from type II polysomnography
|
Central Apnea-Hypopnea Index: (Central apneas with no oxygen desaturation threshold used and with or without arousal+ hypopneas with > 30% flow reduction and >= 4% oxygen desaturation or with arousal) / hour of sleep from type II polysomnography
Calculated - Summary metric of sleep disordered breathing events. |
Sleep Monitoring/Polysomnography/Apnea-Hypopnea Indices | |
ahi_o0h3
Obstructive Apnea-Hypopnea Index: (Obstructive apneas with no oxygen desaturation threshold used and with or without arousal+ hypopneas with > 30% flow reduction and >= 3% oxygen desaturation and with or without arousal) / hour of sleep from type II polysomnography
|
Obstructive Apnea-Hypopnea Index: (Obstructive apneas with no oxygen desaturation threshold used and with or without arousal+ hypopneas with > 30% flow reduction and >= 3% oxygen desaturation and with or without arousal) / hour of sleep from type II polysomnography
Calculated - Summary metric of sleep disordered breathing events. |
Sleep Monitoring/Polysomnography/Apnea-Hypopnea Indices | |
ahi_o0h3a
Obstructive Apnea-Hypopnea Index: (Obstructive apneas with no oxygen desaturation threshold used and with or without arousal+ hypopneas with > 30% flow reduction and >= 3% oxygen desaturation or with arousal) / hour of sleep from type II polysomnography
|
Obstructive Apnea-Hypopnea Index: (Obstructive apneas with no oxygen desaturation threshold used and with or without arousal+ hypopneas with > 30% flow reduction and >= 3% oxygen desaturation or with arousal) / hour of sleep from type II polysomnography
Calculated - Summary metric of sleep disordered breathing events. The definition for hypopneas is consistent with the following clinical guidelines: (1) American Academy of Sleep Medicine (AASM) 2007 Manual (2012 update) (recommended). Berry RB et al. 2012 (PubMed ID:23066376), and (2) American Academy of Sleep Medicine (AASM) 2015 (recommended) [Berry RB et al. The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications, Version 2.2. American Academy of Sleep Medicine, Darien, IL, 2015.] |
Sleep Monitoring/Polysomnography/Apnea-Hypopnea Indices | |
ahi_o0h4
Obstructive Apnea-Hypopnea Index: (Obstructive apneas with no oxygen desaturation threshold used and with or without arousal+ hypopneas with > 30% flow reduction and >= 4% oxygen desaturation and with or without arousal) / hour of sleep from type II polysomnography
|
Obstructive Apnea-Hypopnea Index: (Obstructive apneas with no oxygen desaturation threshold used and with or without arousal+ hypopneas with > 30% flow reduction and >= 4% oxygen desaturation and with or without arousal) / hour of sleep from type II polysomnography
Calculated - Summary metric of sleep disordered breathing events. The definition of hypopnea events is consistent with the following clinical guidelines: (1) AASM 2012 update (alternative) Berry RB et al. 2012 (PubMed ID:23066376), and (2) AASM 2015 (acceptable) [Berry RB et al. The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications, Version 2.2. American Academy of Sleep Medicine, Darien, IL, 2015.]. |
Sleep Monitoring/Polysomnography/Apnea-Hypopnea Indices | |
ahi_o0h4a
Obstructive Apnea-Hypopnea Index: (Obstructive apneas with no oxygen desaturation threshold used and with or without arousal+ hypopneas with > 30% flow reduction and >= 4% oxygen desaturation or with arousal) / hour of sleep from type II polysomnography
|
Obstructive Apnea-Hypopnea Index: (Obstructive apneas with no oxygen desaturation threshold used and with or without arousal+ hypopneas with > 30% flow reduction and >= 4% oxygen desaturation or with arousal) / hour of sleep from type II polysomnography
Calculated - Summary metric of sleep disordered breathing events. |
Sleep Monitoring/Polysomnography/Apnea-Hypopnea Indices | |
cai0p
Central Apnea Index: (Central apneas with no oxygen desaturation threshold used and with or without arousal) / hour of sleep from type II polysomnography
|
Central Apnea Index: (Central apneas with no oxygen desaturation threshold used and with or without arousal) / hour of sleep from type II polysomnography
Calculated - Summary metric of sleep disordered breathing events |
Sleep Monitoring/Polysomnography/Apnea-Hypopnea Indices | |
oai0p
Obstructive Apnea Index: (Obstructive apneas with no oxygen desaturation threshold used and with or without arousal) / hour of sleep from type II polysomnography
|
Obstructive Apnea Index: (Obstructive apneas with no oxygen desaturation threshold used and with or without arousal) / hour of sleep from type II polysomnography
Calculated - Summary metric of sleep disordered breathing events |
Sleep Monitoring/Polysomnography/Apnea-Hypopnea Indices | |
rdi0p
Apnea-Hypopnea Index: Apneas with no oxygen desaturation threshold used and with or without arousal+ hypopneas with > 30% flow reduction and with no oxygen desaturation used and with or without arousal / hour of sleep from type II polysomnography
|
Apnea-Hypopnea Index: Apneas with no oxygen desaturation threshold used and with or without arousal+ hypopneas with > 30% flow reduction and with no oxygen desaturation used and with or without arousal / hour of sleep from type II polysomnography
Calculated - Summary metric of sleep disordered breathing events |
Sleep Monitoring/Polysomnography/Apnea-Hypopnea Indices | |
rdi3p
Apnea-Hypopnea Index: Apneas with >=3% oxygen desaturation and with or without arousal+ hypopneas with > 30% flow reduction and >=3% oxygen desaturation and with or without arousal / hour of sleep from type II polysomnography
|
Apnea-Hypopnea Index: Apneas with >=3% oxygen desaturation and with or without arousal+ hypopneas with > 30% flow reduction and >=3% oxygen desaturation and with or without arousal / hour of sleep from type II polysomnography
Calculated - Summary metric of sleep disordered breathing events |
Sleep Monitoring/Polysomnography/Apnea-Hypopnea Indices | |
rdi3pa
Apnea-Hypopnea Index: Apneas with >=3% oxygen desaturation or with arousal+ hypopneas with > 30% flow reduction and >=3% oxygen desaturation or with arousal / hour of sleep from type II polysomnography
|
Apnea-Hypopnea Index: Apneas with >=3% oxygen desaturation or with arousal+ hypopneas with > 30% flow reduction and >=3% oxygen desaturation or with arousal / hour of sleep from type II polysomnography
Calculated - Summary metric of sleep disordered breathing events |
Sleep Monitoring/Polysomnography/Apnea-Hypopnea Indices | |
rdi4p
Apnea-Hypopnea Index: Apneas with >=4% oxygen desaturation and with or without arousal+ hypopneas with > 30% flow reduction and >=4% oxygen desaturation and with or without arousal / hour of sleep from type II polysomnography
|
Apnea-Hypopnea Index: Apneas with >=4% oxygen desaturation and with or without arousal+ hypopneas with > 30% flow reduction and >=4% oxygen desaturation and with or without arousal / hour of sleep from type II polysomnography
Ratio of the count of all apneas (central and obstructive) and hypopneas associated with at least a >=4% oxygen desaturation to the total sleep time |
Sleep Monitoring/Polysomnography/Apnea-Hypopnea Indices | |
rdinr3p
Apnea-Hypopnea Index (NREM): Apneas with >= 3% oxygen desaturation and with or without arousal+ hypopneas with > 30% flow reduction and with >= 3% oxygen desaturation and with or without arousal / hour of NREM sleep from type II polysomnography
|
Apnea-Hypopnea Index (NREM): Apneas with >= 3% oxygen desaturation and with or without arousal+ hypopneas with > 30% flow reduction and with >= 3% oxygen desaturation and with or without arousal / hour of NREM sleep from type II polysomnography
Calculated - Summary metric of sleep disordered breathing events |
Sleep Monitoring/Polysomnography/Apnea-Hypopnea Indices | |
rdirem3p
Apnea-Hypopnea Index (REM): Apneas with >= 3% oxygen desaturation and with or without arousal+ hypopneas with > 30% flow reduction and with >= 3% oxygen desaturation and with or without arousal / hour of REM sleep from type II polysomnography
|
Apnea-Hypopnea Index (REM): Apneas with >= 3% oxygen desaturation and with or without arousal+ hypopneas with > 30% flow reduction and with >= 3% oxygen desaturation and with or without arousal / hour of REM sleep from type II polysomnography
Calculated - Summary metric of sleep disordered breathing events |
Sleep Monitoring/Polysomnography/Apnea-Hypopnea Indices | |
ai_all
Arousal Index: Arousals per hour of sleep from type II polysomnography
|
Arousal Index: Arousals per hour of sleep from type II polysomnography
Total number of arousals per hour of sleep. Ratio of count of arousals to total sleep time in hours. |
Sleep Monitoring/Polysomnography/Arousals | |
avgsat
Average oxygen saturation during total sleep duration from type II polysomnography
|
Average oxygen saturation during total sleep duration from type II polysomnography | Sleep Monitoring/Polysomnography/Oxygen Saturation | |
minsat
Minimum oxygen saturation during total sleep duration from type II polysomnography
|
Minimum oxygen saturation during total sleep duration from type II polysomnography
Lowest oxygen saturation (SaO2)% during sleep |
Sleep Monitoring/Polysomnography/Oxygen Saturation | |
overall_shhs2
Polysomnography (PSG) Quality Assessment (Sleep Heart Health Study Visit Two (SHHS2)): Overall signal quality
|
Polysomnography (PSG) Quality Assessment (Sleep Heart Health Study Visit Two (SHHS2)): Overall signal quality
Overall study grade as assigned by scorer. These codes reflected the total duration of useable (artifact free, scorable) signals during sleep time across channels, weighing those signals most critical for accurate scoring of respiratory events and staging during sleep time. The Quality Assessment Form for SHHS2 was modified so that the overall quality grade and the signal quality codes were based on signals during sleep time. Since events were only scored during sleep time this provided a more accurate assessment of signal quality during the actual time or scoring. This change would only have affected the quality grade of a small number of studies in SHHS1 where there was a significant amount of time awake with very good signals combined with very poor signals that occurred during sleep. The overall and signal quality grades are comparable between SHHS1 and SHHS2. |
Sleep Monitoring/Polysomnography/Signal Quality/SHHS2 | |
nsupinep
Percentage of total sleep duration in non-supine position from type II polysomnography
|
Percentage of total sleep duration in non-supine position from type II polysomnography
Percent of sleep time in non-supine body position |
Sleep Monitoring/Polysomnography/Sleep Architecture | |
slpeffp
Sleep Efficiency: the ratio of sleep duration (i.e., total sleep time) to in-bed period (i.e., time in bed) from type II polysomnography
|
Sleep Efficiency: the ratio of sleep duration (i.e., total sleep time) to in-bed period (i.e., time in bed) from type II polysomnography
Sleep duration is the interval between sleep onset time and lights on/out-bed time while asleep (i.e. total sleep time, TST), while in-bed period is the interval between lights off/in-bed time and lights on/out-bed time (i.e. time in bed, TIB).Percentage of time in bed that was spent sleeping, or the ratio of total sleep time to total time in bed, expressed as a percentage. |
Sleep Monitoring/Polysomnography/Sleep Architecture | |
slpprdp
Total Sleep Duration: the interval between sleep onset and sleep offset while the participant is asleep from type II polysomnography
|
Total Sleep Duration: the interval between sleep onset and sleep offset while the participant is asleep from type II polysomnography
Conventionally this variable would be called total sleep time (TST)(i.e. total time spent in stage 1 or greater). |
Sleep Monitoring/Polysomnography/Sleep Architecture | |
supinep
Percentage of total sleep duration in supine position from type II polysomnography
|
Percentage of total sleep duration in supine position from type II polysomnography | Sleep Monitoring/Polysomnography/Sleep Architecture | |
timeremp
Percentage of total sleep duration in REM from type II polysomnography
|
Percentage of total sleep duration in REM from type II polysomnography
The ratio of time in rapid eye movement sleep (REM) to total sleep time, expressed as a percentage. |
Sleep Monitoring/Polysomnography/Sleep Architecture | |
times34p
Percentage of total sleep duration in stage 3 and 4 from type II polysomnography
|
Percentage of total sleep duration in stage 3 and 4 from type II polysomnography | Sleep Monitoring/Polysomnography/Sleep Architecture | |
timest1p
Percentage of total sleep duration in stage 1 from type II polysomnography
|
Percentage of total sleep duration in stage 1 from type II polysomnography | Sleep Monitoring/Polysomnography/Sleep Architecture | |
timest2p
Percentage of total sleep duration in stage 2 from type II polysomnography
|
Percentage of total sleep duration in stage 2 from type II polysomnography | Sleep Monitoring/Polysomnography/Sleep Architecture | |
waso
Wake after Sleep Onset: the total duration between sleep onset and sleep offset time while being awake from type II polysomnography
|
Wake after Sleep Onset: the total duration between sleep onset and sleep offset time while being awake from type II polysomnography
Total amount of time spent awake after going to sleep |
Sleep Monitoring/Polysomnography/Sleep Architecture | |
ess_s1
Epworth Sleepiness Scale: Total score
|
Epworth Sleepiness Scale: Total score
Calculated - Total score based on an 8-item questionnaires ranking likelihood of dozing off Johns MW 1991 (PubMed ID: 1798888). Scale 0-3 for individual items; 0 to 24 for overall score. |
Sleep Questionnaires/Hypersomnia/Epworth Sleepiness Scale (ESS)/SHHS1 | |
ess_s2
Epworth Sleepiness Scale: Total score
|
Epworth Sleepiness Scale: Total score
Calculated - Total score based on an 8-item questionnaires ranking likelihood of dozing off Johns MW 1991 (PubMed ID: 1798888). Scale 0-3 for individual items; 0 to 24 for overall score. |
Sleep Questionnaires/Hypersomnia/Epworth Sleepiness Scale (ESS)/SHHS2 | |
sh317
Sleep Habits (Sleep Heart Health Study Visit Two (SHHS2)): Doctor of Medicine (MD) diagnosed sleep disorder
|
Sleep Habits (Sleep Heart Health Study Visit Two (SHHS2)): Doctor of Medicine (MD) diagnosed sleep disorder
17. Have you ever been told by a doctor that you have a sleep disorder (other than sleep apnea)? |
Sleep Questionnaires/Sleep Disorder | |
saqli
The Short Sleep Apnea Quality of Life Index (SAQLI) Score
|
The Short Sleep Apnea Quality of Life Index (SAQLI) Score
The Short Sleep Apnea Quality of Life Index (Short SAQLI) score |
Sleep Questionnaires/Sleep Disordered Breathing | |
fosq
Functional Outcomes of Sleep Questionnaire (FOSQ) Score
|
Functional Outcomes of Sleep Questionnaire (FOSQ) Score | Sleep Questionnaires/Sleep Disturbance | |
pptid
New SHHS participant ID assigned by BioLINCC
|
New SHHS participant ID assigned by BioLINCC
This participant ID matches what is present in Biologic Specimen and Data Repository Information Coordinating Center (BioLINCC). From BioLINCC, this column may be called 'npptid'. |
Administrative | |
calldt
Interim Follow-up: Days from index date to call
|
Interim Follow-up: Days from index date to call | Administrative/Interim | |
cmplbp
Interim Follow-up: Completed blood pressure (BP)
|
Interim Follow-up: Completed blood pressure (BP) | Administrative/Interim | |
cmplcvd
Interim Follow-up: Completed cardiovascular disease (CVD) events form (parent study form)
|
Interim Follow-up: Completed cardiovascular disease (CVD) events form (parent study form) | Administrative/Interim | |
cmplmeds
Interim Follow-up: Completed medication form
|
Interim Follow-up: Completed medication form | Administrative/Interim | |
cmplshq
Interim Follow-up: Completed sleep health questionnaire form
|
Interim Follow-up: Completed sleep health questionnaire form | Administrative/Interim | |
cmplwt
Interim Follow-up: Completed weight
|
Interim Follow-up: Completed weight | Administrative/Interim | |
comments
Interim Follow-up: Any comments
|
Interim Follow-up: Any comments | Administrative/Interim | |
completeddt_scr
Interim Follow-up: Days from index date to date when screener form was completed
|
Interim Follow-up: Days from index date to date when screener form was completed | Administrative/Interim | |
completeddt_stat
Interim Follow-up: Days from index date to date when status form was completed
|
Interim Follow-up: Days from index date to date when status form was completed | Administrative/Interim | |
contact
Interim Follow-up: Able to contact participant
|
Interim Follow-up: Able to contact participant | Administrative/Interim | |
formdt
Interim Follow-up: Days from index date to date when form was filled out
|
Interim Follow-up: Days from index date to date when form was filled out | Administrative/Interim | |
fup_all
Interim Follow-up: All followup forms present
|
Interim Follow-up: All followup forms present | Administrative/Interim | |
fup_scr
Interim Follow-up: Contact Form present
|
Interim Follow-up: Contact Form present | Administrative/Interim | |
fup_slpsym
Interim Follow-up: Sleep Habits Form present
|
Interim Follow-up: Sleep Habits Form present | Administrative/Interim | |
fup_stat
Interim Follow-up: Status, Blood Pressure and Weight Form present
|
Interim Follow-up: Status, Blood Pressure and Weight Form present | Administrative/Interim | |
fuweight
Interim Follow-up: Follow up (FU) status weight
|
Interim Follow-up: Follow up (FU) status weight
Units are not consistent across observations; use wtunits to determine proper unit. |
Administrative/Interim | |
intrevdt
Interim Follow-up: Days from index date to Interview or Review date
|
Interim Follow-up: Days from index date to Interview or Review date | Administrative/Interim | |
langadmin
Interim Follow-up: Language in which interview was administered
|
Interim Follow-up: Language in which interview was administered | Administrative/Interim | |
nocontact
Interim Follow-up: Reason contact not made
|
Interim Follow-up: Reason contact not made | Administrative/Interim | |
pptstatus
Interim Follow-up: Participant Status
|
Interim Follow-up: Participant Status | Administrative/Interim | |
readin_scr
Interim Follow-up: Days from index date to when screener record was read in at Coordinating Center (CC)
|
Interim Follow-up: Days from index date to when screener record was read in at Coordinating Center (CC) | Administrative/Interim | |
readin_slpsym
Interim Follow-up: Days from index date to when sleep symptoms record was read in at Coordinating Center (CC)
|
Interim Follow-up: Days from index date to when sleep symptoms record was read in at Coordinating Center (CC) | Administrative/Interim | |
readin_stat
Interim Follow-up: Days from index date to when status record was read in at Coordinating Center (CC)
|
Interim Follow-up: Days from index date to when status record was read in at Coordinating Center (CC) | Administrative/Interim | |
reasrefused
Interim Follow-up: Reason refused repeat study
|
Interim Follow-up: Reason refused repeat study | Administrative/Interim | |
repeat
Interim Follow-up: Willing to repeat study
|
Interim Follow-up: Willing to repeat study | Administrative/Interim | |
scrfollowup
Interim Follow-up: Follow-up number
|
Interim Follow-up: Follow-up number | Administrative/Interim | |
spclangadmin
Interim Follow-up: Other language in which interview was administered
|
Interim Follow-up: Other language in which interview was administered | Administrative/Interim | |
spcnocontact
Interim Follow-up: Other reason contact not made
|
Interim Follow-up: Other reason contact not made | Administrative/Interim | |
spcreasrefused
Interim Follow-up: Other reason refused repeat study
|
Interim Follow-up: Other reason refused repeat study | Administrative/Interim | |
statusother
Interim Follow-up: Participant Status - other (text)
|
Interim Follow-up: Participant Status - other (text) | Administrative/Interim | |
visitdt
Interim Follow-up: Days from index date to follow-up visit
|
Interim Follow-up: Days from index date to follow-up visit | Administrative/Interim | |
whoadmin
Interim Follow-up: Who administered this form
|
Interim Follow-up: Who administered this form | Administrative/Interim |